Characterizing the Clinical Implications of Histologic Regression in Melanoma Requires Clear Diagnostic Criteria That Are Consistently Applied-Reply

JAMA Dermatol. 2021 Aug 1;157(8):1006-1007. doi: 10.1001/jamadermatol.2021.1497.

Richard A Scolyer^{1

2

3}, Mary-Ann El Sharouni^{1

4}, John F Thompson^{1

2

5}

¹ Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
² Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
³ Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.
⁴ Department of Dermatology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
⁵ Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

No abstract available

Publication types